Literature DB >> 26240701

Indicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitus.

Kunihiko Hashimoto1, Masafumi Koga1.   

Abstract

Recently, it has become clear that mild abnormal glucose tolerance increases the incidence of perinatal maternal-infant complications, and so the definition and diagnostic criteria of gestational diabetes mellitus (GDM) have been changed. Therefore, in patients with GDM and pregnant women with diabetes mellitus, even stricter glycemic control than before is required to reduce the incidence of perinatal maternal-infant complications. Strict glycemic control cannot be attained without an indicator of glycemic control; this review proposes a reliable indicator. The gold standard indicator of glycemic control in patients with diabetes mellitus is hemoglobin A1c (HbA1c); however, we have demonstrated that HbA1c does not reflect glycemic control accurately during pregnancy because of iron deficiency. It has also become clear that glycated albumin, another indicator of glycemic control, is not influenced by iron deficiency and therefore might be a better indicator of glycemic control in patients with GDM and pregnant women with diabetes mellitus. However, large-population epidemiological studies are necessary in order to confirm our proposal. Here, we outline the most recent findings about the indicators of glycemic control during pregnancy including fructosamine and 1,5-anhydroglucitol.

Entities:  

Keywords:  1,5-anhydroglucitol; Diabetes mellitus; Fructosamine; Gestational diabetes; Glycated albumin; Glycemic control; Hemoglobin A1c; Pregnancy

Year:  2015        PMID: 26240701      PMCID: PMC4515444          DOI: 10.4239/wjd.v6.i8.1045

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  70 in total

1.  1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.

Authors:  Kathleen M Dungan; John B Buse; Joseph Largay; Mary M Kelly; Eric A Button; Shuhei Kato; Steven Wittlin
Journal:  Diabetes Care       Date:  2006-06       Impact factor: 19.112

2.  1,5-Anhydroglucitol levels are low irrespective of plasma glucose levels in patients with chronic liver disease.

Authors:  Masafumi Koga; Jun Murai; Hiroshi Saito; Mikio Mukai; Daishu Toya; Nobuyoshi Tanaka; Hideo Kanehara; Yukihiro Bando; Soji Kasayama
Journal:  Ann Clin Biochem       Date:  2010-08-24       Impact factor: 2.057

3.  The influence of traditional Chinese herbal drugs on serum 1, 5-anhydroglucitol levels.

Authors:  T Kawasaki; T Yamanouchi; A Kashiwabara; T Inoue; T Yoshimura; S Fujimori; T Tanabe; Y Aiso
Journal:  Diabetes Res Clin Pract       Date:  2000-10       Impact factor: 5.602

Review 4.  1,5-Anhydroglucitol and glycated albumin in glycemia.

Authors:  Masafumi Koga
Journal:  Adv Clin Chem       Date:  2014       Impact factor: 5.394

5.  Serum levels of 1,5-anhydro-D-glucitol during the normal and diabetic pregnancy and puerperium.

Authors:  M Tetsuo; T Hamada; K Yoshimatsu; J Ishimatsu; T Matsunaga
Journal:  Acta Obstet Gynecol Scand       Date:  1990       Impact factor: 3.636

6.  Hypertension and pre-eclampsia in women with gestational glucose intolerance.

Authors:  L Suhonen; K Teramo
Journal:  Acta Obstet Gynecol Scand       Date:  1993-05       Impact factor: 3.636

7.  Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control.

Authors:  T Yamanouchi; N Ogata; T Tagaya; T Kawasaki; N Sekino; H Funato; L Akaoka; H Miyashita
Journal:  Lancet       Date:  1996-06-01       Impact factor: 79.321

Review 8.  Infants of diabetic mothers.

Authors:  Joan L Nold; Michael K Georgieff
Journal:  Pediatr Clin North Am       Date:  2004-06       Impact factor: 3.278

9.  Influence of serum proteins on fructosamine concentration in multiple myeloma.

Authors:  M P Montagna; F Laghi; G Cremona; C Zuppi; G Barbaresi; M L Castellana
Journal:  Clin Chim Acta       Date:  1991-12-31       Impact factor: 3.786

10.  Rationale for insulin management in gestational diabetes mellitus.

Authors:  O Langer; M Berkus; L Brustman; A Anyaegbunam; R Mazze
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

View more
  17 in total

Review 1.  Inpatient Glycemic Management of the Pregnant Patient.

Authors:  Tiffany Yeh; Michele Yeung; Felicia A Mendelsohn Curanaj
Journal:  Curr Diab Rep       Date:  2018-08-15       Impact factor: 4.810

2.  The influence of D-chiro-inositol and D-myo-inositol in pregnant women with glucose intolerance.

Authors:  Domenico Dell'Edera; Francesca Sarlo; Arianna Allegretti; Francesca Simone; Maria Giovanna Lupo; Annunziata Anna Epifania
Journal:  Biomed Rep       Date:  2017-07-04

3.  Metabolomics analysis of a mouse model for chronic exposure to ambient PM2.5.

Authors:  Yanyi Xu; Wanjun Wang; Ji Zhou; Minjie Chen; Xingke Huang; Yaning Zhu; Xiaoyun Xie; Weihua Li; Yuhao Zhang; Haidong Kan; Zhekang Ying
Journal:  Environ Pollut       Date:  2019-02-01       Impact factor: 8.071

4.  Inverse association between 1,5-anhydroglucitol and neonatal diabetic complications.

Authors:  Enav Yefet; Shams Twafra; Neta Shwartz; Noura Hissin; Jamal Hasanein; Raul Colodner; Neetsa Mirsky; Zohar Nachum
Journal:  Endocrine       Date:  2019-08-21       Impact factor: 3.633

Review 5.  Haemoglobin A1c or Glycated Albumin for Diagnosis and Monitoring Diabetes: An African Perspective.

Authors:  J A George; R T Erasmus
Journal:  Indian J Clin Biochem       Date:  2018-05-03

6.  Expression of Hepcidin and Ferroportin in the Placenta, and Ferritin and Transferrin Receptor 1 Levels in Maternal and Umbilical Cord Blood in Pregnant Women with and without Gestational Diabetes.

Authors:  Anqiang Yang; Jun Zhao; Minhua Lu; Ying Gu; Yunlong Zhu; Daozhen Chen; Jinyan Fu
Journal:  Int J Environ Res Public Health       Date:  2016-07-28       Impact factor: 3.390

7.  Leukocyte Telomere Length in the Neonatal Offspring of Mothers with Gestational and Pre-Gestational Diabetes.

Authors:  Christopher Gilfillan; Pratyusha Naidu; Florence Gunawan; Fadwa Hassan; Pei Tian; Ngaire Elwood
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

8.  Changes in antidiabetic prescription patterns and indicators of diabetic control among 200,000 patients over 13 years at a single institution in Japan.

Authors:  Kazutoshi Fujibayashi; Michio Hayashi; Hirohide Yokokawa; Toshio Naito
Journal:  Diabetol Metab Syndr       Date:  2016-11-10       Impact factor: 3.320

Review 9.  Metabolomic Biomarkers in Gestational Diabetes Mellitus: A Review of the Evidence.

Authors:  Simon Alesi; Drishti Ghelani; Kate Rassie; Aya Mousa
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

10.  Glycated albumin is an optimal biomarker for gestational diabetes mellitus.

Authors:  Yaping Huang; Yongwei Hu; Y U Ma; Guangyong Ye
Journal:  Exp Ther Med       Date:  2015-10-16       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.